A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer

NCT00625430 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: Gene Directed Enzyme Prodrug Therapy, FP253/Fludarabine

Sponsor

Biotech Equity Partners Pty Ltd